US 11124839
Methods of treating cancer patients with farnesyltransferase inhibitors
granted A61KA61K31/00A61K31/4709
Quick answer
US patent 11124839 (Methods of treating cancer patients with farnesyltransferase inhibitors) held by Kura Oncology, Inc. expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kura Oncology, Inc.
- Grant date
- Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/00, A61K31/4709, A61P, A61P35/00